KRW 12000.0
(-11.37%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 40.18 Billion KRW | 4.07% |
2022 | 37.18 Billion KRW | 23.73% |
2021 | 30.05 Billion KRW | 4.74% |
2020 | 28.69 Billion KRW | 3.09% |
2019 | 27.83 Billion KRW | 1.3% |
2018 | 27.47 Billion KRW | -3.65% |
2017 | 28.51 Billion KRW | 95.62% |
2016 | 14.57 Billion KRW | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 11.05 Billion KRW | 20.25% |
2024 Q2 | 10.23 Billion KRW | -3.82% |
2023 Q1 | 10.09 Billion KRW | -10.1% |
2023 Q2 | 9.7 Billion KRW | -3.92% |
2023 Q3 | 9.7 Billion KRW | 0.08% |
2023 Q4 | 9.19 Billion KRW | -5.3% |
2023 FY | 38.7 Billion KRW | 4.07% |
2022 Q2 | 8.17 Billion KRW | -0.64% |
2022 FY | 37.18 Billion KRW | 23.73% |
2022 Q4 | 11.23 Billion KRW | 17.66% |
2022 Q3 | 9.54 Billion KRW | 16.71% |
2022 Q1 | 8.23 Billion KRW | 0.38% |
2021 Q3 | 7.09 Billion KRW | 0.0% |
2021 FY | 30.05 Billion KRW | 4.74% |
2021 Q4 | 8.2 Billion KRW | 15.61% |
2020 FY | 28.69 Billion KRW | 3.09% |
2019 FY | 27.83 Billion KRW | 1.3% |
2018 FY | 27.47 Billion KRW | -3.65% |
2017 FY | 28.51 Billion KRW | 95.62% |
2016 FY | 14.57 Billion KRW | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
HLB Co., Ltd. | -6.01 Billion KRW | 768.345% |
iNtRON Biotechnology, Inc. | 4.56 Billion KRW | -781.062% |
BINEX Co., Ltd. | 56.65 Billion KRW | 29.073% |
Bioneer Corporation | 199.25 Billion KRW | 79.833% |
Anterogen.Co.,Ltd. | 2.21 Billion KRW | -1715.46% |
CrystalGenomics, Inc. | 1.45 Billion KRW | -2657.994% |
Helixmith Co., Ltd | 2.12 Billion KRW | -1793.824% |
Chabiotech Co.,Ltd. | 255.19 Billion KRW | 84.253% |
Medy-Tox Inc. | 128.16 Billion KRW | 68.646% |
Peptron, Inc. | 1.14 Billion KRW | -3423.134% |
Amicogen, Inc. | 51.51 Billion KRW | 21.992% |
Genexine, Inc. | 387.48 Million KRW | -10270.503% |
HLB Therapeutics Co.,Ltd. | 6.69 Billion KRW | -500.278% |
LegoChem Biosciences, Inc. | 17.79 Billion KRW | -125.788% |
ALTEOGEN Inc. | 31.19 Billion KRW | -28.801% |
PharmaResearch Co., Ltd. | 182.25 Billion KRW | 77.952% |
SillaJen, Inc. | 1.45 Billion KRW | -2658.491% |
JETEMA, Co., Ltd. | 26.58 Billion KRW | -51.171% |
OliX Pharmaceuticals,Inc | 14.42 Billion KRW | -178.625% |
Genomictree Inc. | -1.03 Billion KRW | 3969.09% |
MedPacto, Inc. | -1.83 Billion KRW | 2292.66% |
D&D Pharmatech | 18.67 Billion KRW | -115.153% |
EASY BIO,Inc. | 50.88 Billion KRW | 21.031% |
GI Innovation, Inc. | 1.98 Billion KRW | -1919.888% |